HaleonMEX:HLNN 74 OCF Margin % is 28.95% as of Dec. 2025, which is 56% above its 10-year median of 18.58. GuruFocus rates MEX:HLNN with a GF Score™ of 74/100 and a GF Value™ of MXN107.88. The stock has 3 warning signs investors should review. Among 959 Drug Manufacturers companies, Haleon ranks better than 84.98% on this metric.
OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Haleon's Cash Flow from Operations for the
six
months ended in Dec. 2025 was MXN38,735 Mil. Haleon's Revenue for the
six
months ended in Dec. 2025 was MXN133,777 Mil. Therefore, Haleon's OCF Margin % for the quarter that ended in Dec. 2025 was 28.95%.
The historical rank and industry rank for Haleon's OCF Margin % or its related term are showing as below:
MEX:HLNN'
s OCF Margin % Range Over the Past 10 Years
Min: 9.27 Med: 18.58 Max: 23.88
Current: 23.72
During the past 7 years, the highest OCF Margin % of Haleon was 23.88%. The lowest was 9.27%. And the median was 18.58%.
MEX:HLNN's OCF Margin % is ranked better than 84.98% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs MEX:HLNN: 23.72
Haleon OCF Margin % Related Terms
Haleon OCF Margin % Historical Data
* Premium members only.
The historical data trend for Haleon's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:HLNN vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haleon OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haleon's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Haleon's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haleon (MEX:HLNN) has a OCF Margin % of 28.95% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Haleon and its competitors. This is 56% above median its historical median of 18.58. Over the past decade, Haleon's OCF Margin % has ranged from 9.27 to 23.88. According to the industry distribution chart, Haleon ranks #144 out of 959 companies in the Drug Manufacturers industry, placing it in the top 15%.
Is Haleon's OCF Margin % too high?
Haleon's current OCF Margin % of 28.95% is 56% above median its 10-year median of 18.58. Over the past 10 years, this metric has ranged from a low of 9.27 to a high of 23.88. The Drug Manufacturers industry median OCF Margin % is 9.95. Haleon's value of 28.95% is 191% above this industry median. Based on the distribution chart, Haleon ranks #144 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Haleon has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Haleon's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Haleon ranks #144 out of 959 companies for OCF Margin %. This places Haleon in the top 15% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.95. Haleon's value of 28.95% is 191% above this benchmark. Historically, Haleon's own OCF Margin % has ranged from 9.27 to 23.88 over the past decade. While the company's 10-year median is 18.58 vs. the industry median of 9.95, Haleon has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haleon's current OCF Margin % of 28.95% is 191% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Haleon and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haleon's current OCF Margin % is 28.95%, which is 56% above median its own 10-year median of 18.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleon stock overvalued right now?
Haleon (MEX:HLNN) has a current OCF Margin % of 28.95%. The stock's GF Value™ is MXN107.88, compared to a current price of MXN99.17 — trading 8.1% below its estimated fair value. The current OCF Margin % is 28.95%, which is 56% above median its 10-year median of 18.58 and 191% above the Drug Manufacturers industry median of 9.95. Haleon's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Haleon (MEX:HLNN), the current OCF Margin % is 28.95% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Haleon (MEX:HLNN) Overvalued in 2026?
Based on GuruFocus' analysis, Haleon stock appears to be undervalued.
The current stock price of MXN99.17 is trading 8.1% below its estimated GF Value™ of MXN107.88.
Key valuation signals for MEX:HLNN:
OCF Margin %: 28.95% (56% above median its 10-year median of 18.58)
GF Value™: MXN107.88 vs. price of MXN99.17 (8.1% below fair value)
Industry Position: 191% above the Drug Manufacturers median (#144 of 959)
No single metric tells the full story. See the MEX:HLNN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
74GF Score
Get the complete analysis for MEX:HLNN
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:HLNN has been successfully added to your 
